Clinical trial
Optimizing PrEP Implementation and Effectiveness Among Women at High Risk for HIV Acquisition in South Africa: Phase 2b
NCT06274060 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing PrEP Implementation and Effectiveness Among Women at High Risk for HIV Acquisition in South Africa: Phase 2b
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 16, 2024
- Completion date
- June 1, 2025
- Enrollment
- 304 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infections, pre-exposure prophylaxis